Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
0 drugs in development·0 companies·1 clinical trial
Deep-dive into Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis